Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Return on Capital Employed (2018 - 2021)

Cogent Biosciences (COGT) has 4 years of Return on Capital Employed data on record, last reported at 0.3% in Q3 2021.

  • For Q3 2021, Return on Capital Employed rose 75.0% year-over-year to 0.3%; the TTM value through Sep 2021 reached 0.3%, up 75.0%, while the annual FY2020 figure was 0.6%, 1.0% down from the prior year.
  • Return on Capital Employed reached 0.3% in Q3 2021 per COGT's latest filing, up from 0.45% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.3% in Q3 2021 and bottomed at 1.11% in Q3 2019.
  • Average Return on Capital Employed over 4 years is 0.69%, with a median of 0.74% recorded in 2019.
  • Peak YoY movement for Return on Capital Employed: dropped -25bps in 2019, then skyrocketed 75bps in 2021.
  • A 4-year view of Return on Capital Employed shows it stood at 0.55% in 2018, then tumbled by -45bps to 0.8% in 2019, then soared by 43bps to 0.45% in 2020, then soared by 34bps to 0.3% in 2021.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.3% in Q3 2021, 0.45% in Q2 2021, and 0.38% in Q1 2021.